Ivermectin, HCQ dropped from revised clinical guidance
The reasons behind dropping Hydroxychloroquine also included no mortality benefit, increases the risk of address drug effect (ADE) when co-administered with Azithromycin
The reasons behind dropping Hydroxychloroquine also included no mortality benefit, increases the risk of address drug effect (ADE) when co-administered with Azithromycin
Numolux CEO Hilton Klein said that there are roughly 24 million children and teenagers in South Africa, and that if the vaccine made by Sinovac is approved for use on them, it will help the country reach herd immunity more quickly
